Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis [Phase 3]
Phase III clinical trial update for minodronate tablets in postmenopausal osteoporosis; status not specified.
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051) [Phase 3]
A long-term extension of the FIT fracture intervention trial (Phase 3) for osteoporosis in postmenopausal individuals has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: Trial to Evaluate Tibolone in the Treatment of Osteoporosis (P06468) [Phase 3]
Phase 3 clinical trial evaluating tibolone for osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: Effects of Denosumab on Bone Fusion in Osteoporotic Patients After Lumbar Fusion [Phase 4]
Phase 4 trial investigating denosumab's effects on bone fusion in osteoporotic patients after lumbar fusion.
-
CLINICAL_TRIALS trial_result · 2022-01-06Clinical Trial Update: Selenium for Musculoskeletal Health [Phase 3]
Phase 3 clinical trial update on selenium for musculoskeletal health in osteoporosis patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Simvastatin to Prevent SCI-Induced Bone Loss [Phase 2]
Phase 2 clinical trial investigating simvastatin to prevent bone loss after spinal cord injury.
-
CLINICAL_TRIALS trial_result · 2021-11-12Clinical Trial Update: Alendronate Versus Denosumab in Kidney Transplant Patients [Phase 2, Phase 3]
A randomized trial comparing alendronate to denosumab in kidney transplant recipients with osteoporosis or osteopenia has completed Phase 2/…
-
CLINICAL_TRIALS trial_result · 2021-10-18Clinical Trial Update: 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis [NA]
Clinical trial update on 99Tc-MDP in postmenopausal women with differentiated thyroid cancer and osteoporosis; trial completed with results …
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption [Phase 3]
Phase 3 trial update assessing early effects of abaloparatide on tissue-based indices of bone formation and resorption in osteoporosis, with…
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment [Phase 4]
Phase 4 trial comparing brand-name versus generic alendronate for osteoporosis evaluated efficacy and safety; results posted after completio…
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy [Phase 2]
Phase 2 trial evaluating how the administration period of teriparatide influences bone metabolism and bone mineral density before denosumab …
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: Efficacy of Zoledronic Acid in Osteoporosis [Phase 2]
Phase 2 trial update evaluating the efficacy of Zoledronic Acid in osteoporosis.
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: Efficacy of Oral Ibandronate in Osteoporosis [Phase 2]
Phase 2 trial update evaluating the efficacy of oral ibandronate for osteoporosis.
-
CLINICAL_TRIALS trial_result · 2021-09-21Clinical Trial Update: Changes of Bone Turnover Markers and Bone Mineral Density After Osteoporosis Treatment [Phase 4]
Phase 4 clinical trial update examining changes in bone turnover markers and bone mineral density following osteoporosis treatment.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Growth Hormone Therapy and Bone Quality in Pediatric Osteoporosis [Phase 3]
Phase 3 clinical trial evaluating growth hormone therapy for bone quality in pediatric osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-28Clinical Trial Update: A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass [Phase 2]
A completed Phase 2 study evaluating oral hPTH(1-34) (EBP05) in postmenopausal women with low bone mass (osteoporosis).
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Intervention on Osteoporosis and Chronic Kidney Disease-mineral and Bone Disorder (CKD-MBD) [NA]
Clinical trial update for an intervention in osteoporosis and CKD-MBD is terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Prevention of Bone Loss After Acute SCI by Zoledronic Acid [Phase 2]
A Phase 2 trial testing zoledronic acid to prevent bone loss after acute spinal cord injury has completed, with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Disproxil [Phase 4]
A Phase 4 clinical trial update examining changes in weight, body composition, and metabolic parameters after discontinuation of dolutegravi…
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Calcium Supplementation in Postmenopausal Women [Phase 3]
Phase 3 clinical trial update evaluating calcium supplementation in postmenopausal women with osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: Effect of Atorvastatin on Bone-vascular Axis [Phase 4]
Phase 4 trial evaluating the effect of atorvastatin on bone-vascular axis in osteoporosis and hypercholesterolemia; completed with results p…
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: Open Label Extension [Phase 3]
Open-label extension update for a Phase 3 osteoporosis trial; the study has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: Open Label Extension Study of PREOS [Phase 3]
Open-label extension study update for PREOS in osteoporosis.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal Osteoporosis [Phase 2]
Phase 2 trial assessing safety and efficacy of three doses of ALX1-11 in postmenopausal osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis [Phase 3]
Phase 3 trial update on recombinant human parathyroid hormone (ALX1-11) assessing fracture incidence in postmenopausal osteoporosis has comp…